(-0.11%) 5 207.00 points
(-0.07%) 39 167 points
(-0.17%) 18 155 points
(0.54%) $79.42
(0.23%) $2.19
(0.08%) $2 324.10
(1.01%) $27.88
(0.73%) $991.80
(0.08%) $0.931
(0.14%) $10.91
(0.07%) $0.801
(0.29%) $92.00
Live Chart Being Loaded With Signals
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite...
Stats | |
---|---|
Today's Volume | 911 353 |
Average Volume | 1.59M |
Market Cap | 12.36B |
EPS | INR0 ( 2024-02-14 ) |
Next earnings date | ( INR0 ) 2024-05-27 |
Last Dividend | INR0 ( N/A ) |
Next Dividend | INR0 ( N/A ) |
P/E | 37.57 |
ATR14 | INR0.0510 (0.39%) |
Volume Correlation
Syncom Formulations Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Syncom Formulations Correlation - Currency/Commodity
Syncom Formulations Financials
Annual | 2022 |
Revenue: | INR2.24B |
Gross Profit: | INR825.58M (36.81 %) |
EPS: | INR0.220 |
FY | 2022 |
Revenue: | INR2.24B |
Gross Profit: | INR825.58M (36.81 %) |
EPS: | INR0.220 |
FY | 2022 |
Revenue: | INR2.18B |
Gross Profit: | INR709.74M (32.58 %) |
EPS: | INR0.240 |
FY | 2021 |
Revenue: | INR2.39B |
Gross Profit: | INR722.43M (30.19 %) |
EPS: | INR0.380 |
Financial Reports:
No articles found.
Syncom Formulations
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Further, the company exports its products. It offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators